Clarus Therapeutics, Inc.
Records under this name other than patents Clarus Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Clarus Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,331,325 | Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same now held by Tolmar, Inc. In force · High confidence | In force | High confidence | |
| US 8,241,664 | Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Compositions Comprising Same now held by Tolmar, Inc. In force · High confidence | In force | High confidence | |
| US 8,778,916 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same now held by Tolmar, Inc. In force · High confidence | In force | High confidence | |
| US 10,543,219 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same now held by Tolmar, Inc. In force · High confidence | In force | High confidence | |
| US 10,617,696 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same now held by Tolmar, Inc. In force · High confidence | In force | High confidence | |
| US 11,179,403 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same now held by Tolmar, Inc. In force · High confidence | In force | High confidence | |
| US 11,426,416 | Oral Testosterone Ester Formulations and Methods of Treating Testosterone Deficiency Comprising Same now held by Tolmar, Inc. In force · High confidence | In force | High confidence | |
| US 10,245,273 | Oral Pharmaceutical Products and Methods of Use Combining Testosterone Esters with Hypolipidemic Agents now held by Tolmar, Inc. In force · High confidence | In force | High confidence | |
| US 11,564,933 | Methods of Treating Testosterone Deficiency now held by Tolmar, Inc. In force · High confidence | In force | High confidence | |
| US 8,778,917 | Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Comprising Same now held by Tolmar, Inc. Term ended Term ended Apr 14, 2026 · High confidence | Term ended | Term ended Apr 14, 2026 | High confidence |